Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 731 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact731 DOIs

Attach ORCID iDs across 234 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact234 DOIs

Deposit reference lists for 51 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact51 DOIs

DOIs for this ISSN

Showing the top 5 of 731 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Protocol design and synopsis: Omalizumab as Monotherapy and… (10.1016/j.jacig.2022.05.006)	Abstract ORCID	86.21	52
2	Short-chain fatty acids ameliorate allergic airway inflammat… (10.1016/j.jacig.2023.100163)	Abstract ORCID	80.10	39
3	Phase 2b randomized trial of OX40 inhibitor telazorlimab for… (10.1016/j.jacig.2023.100195)	Abstract ORCID	79.55	38
4	Preclinical and clinical experience with dupilumab on the co… (10.1016/j.jacig.2021.12.003)	Abstract ORCID	69.01	23
5	The conundrum of COVID-19 mRNA vaccine–induced anaphylaxis (10.1016/j.jacig.2022.10.003)	Abstract ORCID	63.94	18
6	Type I and type IIb autoimmune chronic spontaneous urticaria… (10.1016/j.jacig.2023.100159)	Abstract ORCID	63.94	18
7	Is pea our hidden allergen? An American pediatric case serie… (10.1016/j.jacig.2023.100090)	Abstract ORCID	60.21	15
8	Low frequency of allergy referral for penicillin allergy eva… (10.1016/j.jacig.2022.09.004)	Abstract ORCID	57.31	13
9	Bronchiectasis in severe asthma is associated with eosinophi… (10.1016/j.jacig.2022.10.001)	Abstract ORCID	55.70	12
10	Dupilumab for cancer-associated refractory pruritus (10.1016/j.jacig.2023.100128)	Abstract ORCID	55.70	12
11	Maternal antibiotic exposure and childhood allergies: The Ja… (10.1016/j.jacig.2023.100137)	Abstract ORCID	52.07	10
12	Prevalence and risk factors for allergic sensitization: 3 cr… (10.1016/j.jacig.2023.100150)	Abstract ORCID	52.07	10
13	IgE reactivity patterns in Asian and central European cockro… (10.1016/j.jacig.2022.04.003)	Abstract ORCID	50.00	9
14	Medication beliefs, adherence, and outcomes in people with a… (10.1016/j.jacig.2022.09.006)	Abstract ORCID	50.00	9
15	JAK1 inhibition with abrocitinib decreases allergen-specific… (10.1016/j.jacig.2023.100103)	Abstract ORCID	50.00	9
16	Efficacy and safety of peanut epicutaneous immunotherapy in… (10.1016/j.jacig.2022.07.009)	Abstract ORCID	47.71	8
17	Ketone body augmentation decreases methacholine hyperrespons… (10.1016/j.jacig.2022.08.001)	Abstract ORCID	47.71	8
18	Screening for type II hereditary angioedema—the “poor man’s… (10.1016/j.jacig.2023.100179)	Abstract ORCID	47.71	8
19	Asthma-associated bacterial infections: Are they protective… (10.1016/j.jacig.2022.08.003)	Abstract ORCID	45.15	7
20	Quality of life in allergic rhinitis patients treated with i… (10.1016/j.jacig.2022.09.007)	Abstract ORCID	45.15	7
21	Long-term safety and immunologic outcomes of daily oral immu… (10.1016/j.jacig.2023.100120)	Abstract ORCID	45.15	7
22	Immune system dysregulation preceding a case of laboratory-c… (10.1016/j.jacig.2024.100244)	Abstract ORCID	45.15	7
23	Allergic reactions to the Ad26.COV2.S vaccine in South Afric… (10.1016/j.jacig.2021.12.002)	Abstract ORCID	42.25	6
24	Novel potential treatable traits in asthma: Where is the res… (10.1016/j.jacig.2022.04.001)	Abstract ORCID	42.25	6
25	Vaccine confidence among those living with allergy during th… (10.1016/j.jacig.2023.100079)	Abstract ORCID	42.25	6
26	H influenzae LPS colocalization with Toll-like receptor 4 in… (10.1016/j.jacig.2023.100151)	Abstract ORCID	42.25	6
27	The impact of anaphylaxis on the absorption of intranasal ep… (10.1016/j.jacig.2023.100165)	Abstract ORCID	42.25	6
28	The burden of severe asthma in sub-Saharan Africa: Findings… (10.1016/j.jacig.2024.100209)	Abstract ORCID	42.25	6
29	MASTering systemic mastocytosis: Lessons learned from a larg… (10.1016/j.jacig.2024.100316)	Abstract ORCID	42.25	6
30	Hereditary angioedema with normal C1 inhibitor associated wi… (10.1016/j.jacig.2024.100223)	Abstract	39.21	36
31	Low circulating B cells in immunocompromised individuals are… (10.1016/j.jacig.2022.07.008)	Abstract ORCID	38.91	5
32	Adult asthma prevalence and trend analysis by urban–rural st… (10.1016/j.jacig.2023.100085)	Abstract ORCID	38.91	5
33	Rapid increases in epinephrine concentration following presu… (10.1016/j.jacig.2023.100118)	Abstract ORCID	38.91	5
34	Long-term health care resource and cost savings with allergy… (10.1016/j.jacig.2023.100197)	Abstract ORCID	38.91	5
35	Apolipoprotein A-I inhibited group II innate lymphoid cell r… (10.1016/j.jacig.2024.100212)	Abstract ORCID	38.91	5
36	Prevalence, severity, and risk factors of eczema among young… (10.1016/j.jacig.2024.100299)	Abstract ORCID	38.91	5
37	Effect of prednisone on woodsmoke-induced sputum inflammatio… (10.1016/j.jacig.2024.100347)	Abstract ORCID	38.91	5
38	Alleviating effect of intranasal zinc on symptoms of allergi… (10.1016/j.jacig.2025.100408)	Abstract ORCID	38.91	5
39	Link between gut microbiota dysbiosis and childhood asthma:… (10.1016/j.jacig.2024.100289)	Abstract	37.96	32
40	Rethinking blood eosinophil counts: Epidemiology, associated… (10.1016/j.jacig.2022.09.001)	Abstract	35.78	26
41	A systematic review of allergen cross-reactivity: Translatin… (10.1016/j.jacig.2024.100230)	Abstract	35.78	26
42	Lung function before and after COVID-19 in young adults: A p… (10.1016/j.jacig.2022.03.001)	Abstract	34.95	24
43	Early-life farm exposures and eczema among adults in the Agr… (10.1016/j.jacig.2022.06.002)	Abstract ORCID	34.95	4
44	Efficacy of dupilumab for the treatment of severe skin disea… (10.1016/j.jacig.2022.08.004)	Abstract ORCID	34.95	4
45	Efficacy of Japanese cedar pollen sublingual immunotherapy t… (10.1016/j.jacig.2022.10.006)	Abstract ORCID	34.95	4
46	Lymphocyte stimulation test for diagnosing hen’s egg yolk–in… (10.1016/j.jacig.2023.100138)	Abstract ORCID	34.95	4
47	Case report of a child who may have developed anaphylaxis af… (10.1016/j.jacig.2023.100139)	Abstract ORCID	34.95	4
48	A highly selective KIT inhibitor MOD000001 suppresses IgE-me… (10.1016/j.jacig.2024.100249)	Abstract ORCID	34.95	4
49	PANoptosis opens new treatment options for allergic bronchop… (10.1016/j.jacig.2024.100298)	Abstract ORCID	34.95	4
50	Atopic dermatitis and tobacco smoke exposure during childhoo… (10.1016/j.jacig.2024.100345)	Abstract ORCID	34.95	4